Richard D Katz Insider Trading $ARGS ARGOS THERAPEUTICS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Richard D Katz.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Richard D Katz. Richard D Katz is Ex VP, Fin & Corp, CFO & Treas in ICAGEN INC ($ICGN) and Sr VP, Fin & Corp, CFO & Treas in ICAGEN INC ($ICGN) and Vice President and CFO in ARGOS THERAPEUTICS INC ($ARGS) and VP & Chief Financial Officer in ARGOS THERAPEUTICS INC ($ARGS) and VP and Chief Financial Officer in ARGOS THERAPEUTICS INC ($ARGS) and Chief Financial Officer in Liquidia Technologies Inc ($LQDA).
Richard D Katz in ARGOS THERAPEUTICS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Richard D Katz: Vice President and CFO, VP and Chief Financial Officer, VP & Chief Financial Officer
Holdings: 9,697 shares
Current Value: $47,030
Latest Transaction: Apr 25 2018
$ARGS Market Capitalization: $208.29M
$ARGS Previous Close: $4.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Richard D Katz in ARGOS THERAPEUTICS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARGS, ICGN, LIQDA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 25 2018 | ARGS | ARGOS THERAPEUTICS ... | Katz Richard D | Vice President and ... | Sell | D | 0.00 | 22,629 | 0 | 9,697 | 32.3 K to 9.7 K (-70.00 %) |
| Apr 02 2018 | ARGS | ARGOS THERAPEUTICS ... | Katz Richard D | Vice President and ... | Grant | A | 0.00 | 22,629 | 0 | 32,326 | 9.7 K to 32.3 K (+233.36 %) |
| Apr 02 2018 | ARGS | ARGOS THERAPEUTICS ... | Katz Richard D | Vice President and ... | Grant | A | 0.00 | 22,629 | 0 | 32,326 | 9.7 K to 32.3 K (+233.36 %) |
| Jan 12 2018 | ARGS | ARGOS THERAPEUTICS ... | Katz Richard D | Vice President and ... | Sell | S | 0.16 | 104,435 | 17,200 | 193,959 | 298.4 K to 194 K (-35.00 %) |
| Jan 05 2018 | ARGS | ARGOS THERAPEUTICS ... | Katz Richard D | Vice President and ... | Sell | S | 0.16 | 101,228 | 16,541 | 298,394 | 399.6 K to 298.4 K (-25.33 %) |
| Aug 31 2017 | ARGS | ARGOS THERAPEUTICS ... | Katz Richard D | VP and Chief Financ ... | Grant | A | 0.00 | 395,664 | 0 | 399,622 | 4 K to 399.6 K (+9,996.56 %) |
| Jan 23 2017 | ARGS | ARGOS THERAPEUTICS ... | Katz Richard D | VP & Chief Financia ... | Option Exercise | A | 4.85 | 105,000 | 509,250 | 105,000 | |
| Jan 23 2017 | ARGS | ARGOS THERAPEUTICS ... | Katz Richard D | VP & Chief Financia ... | Grant | A | 0.00 | 3,958 | 0 | 3,958 | 0 to 4 K |
| Jul 13 2016 | ARGS | ARGOS THERAPEUTICS ... | Katz Richard D | VP & Chief Financia ... | Option Exercise | A | 6.30 | 300,000 | 1,890,000 | 300,000 |
Page: 1